🇺🇸 FDA

Intelligence · Clinical Pipeline

Sanofi Pasteur MSD Pipeline

All ClinicalTrials.gov programs at Sanofi Pasteur MSD — phase, modality, and trial IDs.

Programs
83

Quick answer

Sanofi Pasteur MSD has 83 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. Inactivated Poliomyelitis vaccine (IMOVAX)

    Sanofi Pasteur

    Poliomyelitis

    phase 2 mab completed

    1 trial

  2. Inactivated types 1, 2, and 3 poliovirus, D antigens

    Sanofi Pasteur

    Poliomyelitis

    phase 2 mab completed

    1 trial

  3. Iniparib

    Sanofi Pasteur

    Breast Cancer, Metastatic

    phase 2 small molecule completed

    1 trial

  4. Isatuximab

    Sanofi Pasteur

    Relapsed/Refractory Multiple Myeloma

    phase 2 small molecule active

    1 trial

  5. Leflunomide

    Sanofi Pasteur

    Systemic Lupus Eythematosus (SLE)

    phase 2 small molecule completed

    1 trial

  6. Live attenuated Japanese encephalitis virus; Yellow fever virus

    Sanofi Pasteur

    Japanese Encephalitis

    phase 2 mab completed

    1 trial

  7. Lunsekimig

    Sanofi Pasteur

    Asthma

    phase 2 small molecule active

    1 trial

  8. Oxaliplatin

    Sanofi Pasteur

    Uterine Neoplasms

    phase 2 small molecule terminated

    1 trial

  9. Purified Vero Rabies Vaccine Serum Free (VRVg)

    Sanofi Pasteur

    Rabies

    phase 2 mab completed

    1 trial

  10. SAR440340

    Sanofi Pasteur

    Chronic Obstructive Pulmonary Disease

    phase 2 small molecule completed

    1 trial

  11. SAR441566

    Sanofi Pasteur

    Crohn's Disease

    phase 2 small molecule active

    1 trial

  12. SAR442970

    Sanofi Pasteur

    Hidradenitis Suppurativa

    phase 2 small molecule completed

    1 trial

  13. SAR443122

    Sanofi Pasteur

    Colitis Ulcerative

    phase 2 small molecule active

    1 trial

  14. SAR447537

    Sanofi Pasteur

    Alpha 1-Antitrypsin Deficiency

    phase 2 small molecule active

    1 trial

  15. THOR-707

    Sanofi Pasteur

    Malignant Melanoma

    phase 2 small molecule terminated

    1 trial

  16. THOR-707

    Sanofi Pasteur

    Metastasis

    phase 2 small molecule terminated

    1 trial

  17. docetaxel

    Sanofi Pasteur

    Nasopharyngeal Neoplasms

    phase 2 small molecule completed

    1 trial

  18. SAR448501

    Sanofi Pasteur

    B-cell Non Hodgkin Lymphoma

    phase 1 small molecule active

    1 trial

  19. ombrabulin (AVE8062)

    Sanofi Pasteur

    Neoplasms, Malignant

    phase 1 small molecule completed

    1 trial

  20. sarilumab SAR153191 (REGN88)

    Sanofi Pasteur

    Rheumatoid Arthritis

    phase 1 small molecule completed

    1 trial

  21. Bacillus Clausii Multi ATB Resist

    Sanofi Pasteur

    Diarrhea, Infantile

    approved small molecule completed

    1 trial

  22. Dupilumab

    Sanofi Pasteur

    Asthma

    approved small molecule active

    2 trials

  23. Enoxaparin

    Sanofi Pasteur

    Acute Illness

    approved small molecule completed

    1 trial

  24. Fexofenadine

    Sanofi Pasteur

    Rhinitis, Allergic, Perennial

    approved small molecule completed

    1 trial

  25. Fexofenadine HCL and pseudoephedrine HCL

    Sanofi Pasteur

    Rhinitis Allergic

    approved small molecule completed

    1 trial

  26. INSULIN GLARGINE (HOE901)

    Sanofi Pasteur

    Diabetes Mellitus, Type 2

    approved small molecule terminated

    1 trial

  27. Insulin Glargine

    Sanofi Pasteur

    Diabetes Mellitus, Type 2

    approved small molecule completed

    2 trials

  28. Insulin glulisine

    Sanofi Pasteur

    Diabetes Mellitus, Type 1

    approved small molecule completed

    1 trial

  29. Lixisenatide (AVE0010)

    Sanofi Pasteur

    Diabetes Mellitus, Type 2

    approved small molecule completed

    3 trials

  30. RAMIPRIL HOE498

    Sanofi Pasteur

    Coronary Artery Disease

    approved small molecule completed

    1 trial

  31. Shanchol™: Oral Cholera Vaccine Killed Bivalent (O1 and O139) Whole Cell

    Sanofi Pasteur

    Cholera

    approved mab completed

    1 trial

  32. alglucosidase alfa

    Sanofi Pasteur

    Pompe Disease (Infantile-Onset)

    approved mab terminated

    1 trial

  33. alglucosidase alfa

    Sanofi Pasteur

    Pompe Disease

    approved mab completed

    1 trial

  34. rFVIIIFc

    Sanofi Pasteur

    Hemophilia A With Inhibitors

    approved mab completed

    1 trial

  35. risedronate sodium

    Sanofi Pasteur

    Osteoporosis, Postmenopausal

    approved small molecule completed

    1 trial

Frequently asked questions

How many pipeline programs does Sanofi Pasteur MSD have?

83 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.